The PETITE-DTG study evaluated the dosing and safety of dolutegravir (DTG) in neonates born to mothers living with HIV. The study assessed a pediatric dispersible tablet and an oral film, finding the dosing strategy to be safe and effective. The PETITE PLATFORM aims to accelerate neonatal dosing recommendations for ARVs, with the goal of expanding access to the latest advancements in HIV care for newborns. The study showed high levels of acceptability for both DTG formulations, potentially improving HIV prevention and treatment options for neonates.
Full Article
Ekurhuleni valuation roll out for inspection, lodging of objections
The City of Ekurhuleni's fifth General Valuation Roll for July 1, 2025 to June 30, 2029, is open for public comment until June 25, 2025, with objections due by 15:30. Property owners can access the roll at municipal offices or online, and are encouraged to review and submit objections to ensure accurate valuations. Specific objections must be submitted by hand with Section 49 notice to relevant municipal offices, with contact information provided for assistance. Full...
Read more